News Allergan and Gedeon Richter set to expand use of bipolar dru... Companies want Vraylar as option bipolar depression
News Takeda depression app impresses in pilot study App corresponds with standard cognitive and patient-reported assessment measures.
News Lundbeck trial investigates genetic causes of depression New study with 23andMe and Milken Institute looks to determine causes of depression.
News US researchers create AI capable of diagnosing depression Algorithm accurately detects depression from brain scans in 75% of cases.
News Takeda to pilot wearable-based depression app Cognition Kit wearable app measures daily activities and tests cognitive function.
Views & Analysis Fifteen uses for Botox you never knew doctors talked about Other possible benefits include pain and depression.
News Remepy's hybrid Parkinson's therapy poised for phase 3 Remepy's Hybridopa therapy for Parkinson's, which combines an app with levodopa therapy, has shown efficacy in a phase 2 pilot study.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
